As the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) virus continues to
infect patients globally, vaccination remains one of the primary methods to combat this …

Background: The novel SARS-CoV-2 vaccines partially exploit intrinsic DNA or RNA
adjuvanticity, with dysregulation in the metabolism of both these nucleic acids independently …

Umbilical cord blood (UCB) is an irreplaceable source for hematopoietic stem progenitor
cells (HSPCs). However, the effects of SARS-CoV-2 infection and COVID-19 vaccination on …

Background Anti-CD20 is a highly effective therapy for multiple sclerosis (MS), a disease
with multiple abnormalities in function of B and T cells and innate immune cells. Anti-CD20 …

Cellular immunity after SARS-CoV-2 infection or immunization may be important for long-
lasting protection against severe COVID-19 disease. We investigated cellular immune …

We report on an aggressive, infiltrating, metastatic, and ultimately lethal basaloid type of
carcinoma arising shortly after an mRNA vaccination for COVID-19. The wife of the patient …

A systematic review and meta-analysis were performed to evaluate the virus-specific T-cell
response after COVID-19 mRNA vaccination, using the QuantiFERON SARS-CoV-2 …

We describe the results of a T-cell immunity evaluation performed after a median elapsed
time of 7 months from second-dose BNT162b2 vaccine administration, in a representative …

Vaccination against the SARS‐Cov‐2 virus is an effective way to protect against the disease
and the severe course of COVID‐19. Forty‐nine fully vaccinated with mRNA vaccines …

Memory T cell responses have been analyzed only in small cohorts of COVID‐19 vaccines.
Herein, we aimed to assess anti‐SARS‐CoV‐2 cellular immunity in a large cohort using …